Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M-H)- | 1801234 | Peak area | HAHA | TNF-alpha |
Reversed phase NEGATIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M-H)- | 2055456 | Peak area | PAK | IFN-G |
Reversed phase NEGATIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M-H)- | 2081061 | Peak area | HAHA | IL-17A |
Reversed phase NEGATIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M-H)- | 2135973 | Peak area | HAHA | IFN-G |
Reversed phase NEGATIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M-H)- | 2217221 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M-H)- | 2274170 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M-H)- | 2338984 | Peak area | PAK | IL-17A |
Reversed phase NEGATIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M-H)- | 2535703 | Peak area | PAK | TNF-alpha |
Reversed phase NEGATIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M-H)- | 2734032 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M-H)- | 2817842 | Peak area | BS4 | Untreated |
Reversed phase NEGATIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M-H)- | 2872748 | Peak area | BS4 | IL-17A |
Reversed phase NEGATIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M-H)- | 2879624 | Peak area | PAK | Untreated |
Reversed phase NEGATIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M-H)- | 3057400 | Peak area | BS4 | TNF-alpha |
Reversed phase NEGATIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M-H)- | 3431997 | Peak area | BS4 | IFN-G |
Reversed phase NEGATIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M-H)- | Peak area | HAHA | Untreated | |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+ | 1423 | Peak area | HAHA | Untreated |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+ | 9985 | Peak area | BS4 | Untreated |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+ | 12777 | Peak area | PAK | TNF-alpha |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+ | 14890 | Peak area | BS4 | TNF-alpha |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+ | 29655 | Peak area | BS4 | IL-17A |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+ | Peak area | BS4 | IFN-G | |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+ | Peak area | BS4 | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+ | Peak area | HAHA | IFN-G | |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+ | Peak area | HAHA | IL-17A | |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+ | Peak area | HAHA | TNF-alpha | |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+ | Peak area | HAHA | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+ | Peak area | PAK | IFN-G | |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+ | Peak area | PAK | IL-17A | |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+ | Peak area | PAK | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+ | Peak area | PAK | Untreated | |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O] | 14216 | Peak area | PAK | Untreated |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O] | 19872 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O] | 31772 | Peak area | BS4 | IL-17A |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O] | 37706 | Peak area | HAHA | IFN-G |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O] | 81853 | Peak area | PAK | IFN-G |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O] | 93324 | Peak area | HAHA | Untreated |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O] | 111062 | Peak area | HAHA | TNF-alpha |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O] | 125106 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O] | 135012 | Peak area | HAHA | IL-17A |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O] | 191710 | Peak area | PAK | TNF-alpha |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O] | 253884 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O] | 268180 | Peak area | BS4 | IFN-G |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O] | 286445 | Peak area | BS4 | Untreated |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O] | 291820 | Peak area | PAK | IL-17A |
Reversed phase POSITIVE ION MODE | GLUTAMATE (CAS# 56-86-0); (M+H)+[-H2O] | 291916 | Peak area | BS4 | TNF-alpha |